Hanish Arnold C: insider trades.
Hanish Arnold C reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($282K), across 2 companies.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 2
- Name as filed
- HANISH ARNOLD C
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Omeros Corp (OMER) | Director | 6 |
| Decoy Therapeutics Inc. (DCOY) | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Decoy Therapeutics Inc. | A | 3,000 | $0 | 3,418 | Form 4 |
| 2026-08-27 | Omeros Corp | S | 5,000 | $19.02 | 0 | Form 4 |
| 2026-08-27 | Omeros Corp | M | 7,500 | $14.66 | 10,000 | Form 4 |
| 2026-08-27 | Omeros Corp | S | 5,000 | $18.88 | 5,000 | Form 4 |
| 2026-08-27 | Omeros Corp | M | 2,500 | $15.81 | 2,500 | Form 4 |
| 2026-08-26 | Omeros Corp | S | 5,000 | $18.53 | 0 | Form 4 |
| 2026-08-26 | Omeros Corp | M | 5,000 | $15.81 | 5,000 | Form 4 |
Questions
What stock did Hanish Arnold C buy or sell?
Hanish Arnold C reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($282K), across 2 companies.
Is Hanish Arnold C the same person as other filers with this name?
This page covers SEC CIK 1233253 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/hanish-arnold-c-1233253.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.